Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Extracorporeal CO2 Removal Devices Market, by Application
1.4.2 Europe Extracorporeal CO2 Removal Devices Market, by End-Use
1.4.3 Europe Extracorporeal CO2 Removal Devices Market, by Product
1.4.4 Europe Extracorporeal CO2 Removal Devices Market, by Access
1.4.5 Europe Extracorporeal CO2 Removal Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Extracorporeal CO2 Removal Devices Market, By Application
4.1 Europe Bridge To Lung Transplant Market, By Country
4.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Market, By Country
4.3 Europe Acute Respiratory Distress Syndrome (ARDS) Market, By Country
4.4 Europe Others Market, By Country
Chapter 5. Europe Extracorporeal CO2 Removal Devices Market, By End-use
5.1 Europe Hospitals Market, By Country
5.2 Europe Clinics Market, By Country
5.3 Europe Ambulatory Surgical Centers Market, By Country
5.4 Europe Others Market, By Country
Chapter 6. Europe Extracorporeal CO2 Removal Devices Market, By Product
6.1 Europe Extracorporeal CO2 Machines Market, By Country
6.2 Europe Disposables Market, By Country
6.3 Europe Others Market, By Country
Chapter 7. Europe Extracorporeal CO2 Removal Devices Market, By Access
7.1 Europe Arteriovenous Market, By Country
7.2 Europe Venovenous Market, By Country
Chapter 8. Europe Extracorporeal CO2 Removal Devices Market, By Country
8.1 Germany Extracorporeal CO2 Removal Devices Market
8.1.1 Germany Extracorporeal CO2 Removal Devices Market, By Application
8.1.2 Germany Extracorporeal CO2 Removal Devices Market, By End-use
8.1.3 Germany Extracorporeal CO2 Removal Devices Market, By Product
8.1.4 Germany Extracorporeal CO2 Removal Devices Market, By Access
8.2 UK Extracorporeal CO2 Removal Devices Market
8.2.1 UK Extracorporeal CO2 Removal Devices Market, By Application
8.2.2 UK Extracorporeal CO2 Removal Devices Market, By End-use
8.2.3 UK Extracorporeal CO2 Removal Devices Market, By Product
8.2.4 UK Extracorporeal CO2 Removal Devices Market, By Access
8.3 France Extracorporeal CO2 Removal Devices Market
8.3.1 France Extracorporeal CO2 Removal Devices Market, By Application
8.3.2 France Extracorporeal CO2 Removal Devices Market, By End-use
8.3.3 France Extracorporeal CO2 Removal Devices Market, By Product
8.3.4 France Extracorporeal CO2 Removal Devices Market, By Access
8.4 Russia Extracorporeal CO2 Removal Devices Market
8.4.1 Russia Extracorporeal CO2 Removal Devices Market, By Application
8.4.2 Russia Extracorporeal CO2 Removal Devices Market, By End-use
8.4.3 Russia Extracorporeal CO2 Removal Devices Market, By Product
8.4.4 Russia Extracorporeal CO2 Removal Devices Market, By Access
8.5 Spain Extracorporeal CO2 Removal Devices Market
8.5.1 Spain Extracorporeal CO2 Removal Devices Market, By Application
8.5.2 Spain Extracorporeal CO2 Removal Devices Market, By End-use
8.5.3 Spain Extracorporeal CO2 Removal Devices Market, By Product
8.5.4 Spain Extracorporeal CO2 Removal Devices Market, By Access
8.6 Italy Extracorporeal CO2 Removal Devices Market
8.6.1 Italy Extracorporeal CO2 Removal Devices Market, By Application
8.6.2 Italy Extracorporeal CO2 Removal Devices Market, By End-use
8.6.3 Italy Extracorporeal CO2 Removal Devices Market, By Product
8.6.4 Italy Extracorporeal CO2 Removal Devices Market, By Access
8.7 Rest of Europe Extracorporeal CO2 Removal Devices Market
8.7.1 Rest of Europe Extracorporeal CO2 Removal Devices Market, By Application
8.7.2 Rest of Europe Extracorporeal CO2 Removal Devices Market, By End-use
8.7.3 Rest of Europe Extracorporeal CO2 Removal Devices Market, By Product
8.7.4 Rest of Europe Extracorporeal CO2 Removal Devices Market, By Access
Chapter 9. Company Profiles
9.1 Medtronic PLC
9.1.1 Company overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 SWOT Analysis
9.2 Getinge AB
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 Fresenius Medical Care AG & Co. KGaA
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.3.6 SWOT Analysis
9.4 Medica S.p.A.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 SWOT Analysis
9.5 Aferetica srl
9.5.1 Company Overview
9.5.2 SWOT Analysis
9.6 LivaNova PLC
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 ESTOR S.P.A.
9.7.1 Company Overview
9.7.2 SWOT Analysis
9.8 X-COR Therapeutics
9.8.1 Company Overview
9.8.2 SWOT Analysis
Unique Offerings 